Miscellaneous

Conferences & eventsCome & meet our amazing teamGenoskin at the SOT 65th Annual Meeting & ToxExpoDriving innovation in non-clinical toxicity assessment with ex vivo human skin and mast cell models Genoskin was pleased to return to the SOT Annual Meeting and ToxExpo, taking place March 22–25, 2026, at the San Diego Convention Center in San Diego, California. Recognized as oneRead more

Media kit & brand assetsDownload Genoskin's media kit Get a copy of Genoskin's media kit. This document will provide you with all the information regarding Genoskin's activities, executive team and past media coverage. Please fill in the form below to access the media kit. Need more info? Please contact us! Contact us

Top-level science through the eyes of an expert.Skin Deep: how microbes & immunity shape allergic reactionsDid you miss the live session? You can now watch the full webinar replay on demand where Dr. Phlipp Starkl explores how the skin’s immune system balances protection and pathology in response to microbial threats. In this webinar, Dr. Philipp Starkl shared his latest researchRead more

Genoskin awarded the Healthtech prize “Transformons la France!” Yesterday, Genoskin was awarded the Healthtech prize at the “Transformons la France!” (Let’s Transform France!) ceremony presented by La Tribune in Toulouse. While the current health crisis calls into question our lifestyles, "Transformons la France!" highlights the talents of tomorrow and gives impact to those who transform society for the better. TheRead more

Genoskin in the News: article on Benzinga Benzinga biotech reporter Shanthi Rexaline recently spoke to GENOSKIN's CEO Pascal Descargues. In the interview, Pascal shared the inspiration behind founding Genoskin: Pascal quickly realized during his postdoctoral fellowship that animal models were not predictive enough. Pascal also had the opportunity to present Genoskin’s technology. He walked Shanthi through the Genoskin workflow: from sourcingRead more

Genoskin featured in a Business Insider article The press is talking about Genoskin! Amid COVID-19 breakout, Genoskin got attention from Business Insider 's reporter Mia Jankowicz.  We recently communicated on our continued efforts during the pandemic and our preferred access program for research on COVID-19. Genoskin's projects and technology caught the eye of Mia Jankowicz. Mia, a journalist specializing inRead more